S
Soong Ho Kim
Researcher at Icahn School of Medicine at Mount Sinai
Publications - 8
Citations - 496
Soong Ho Kim is an academic researcher from Icahn School of Medicine at Mount Sinai. The author has contributed to research in topics: Latrepirdine & Neurofibrillary tangle. The author has an hindex of 7, co-authored 8 publications receiving 415 citations.
Papers
More filters
Journal ArticleDOI
Characterization and molecular profiling of PSEN1 familial Alzheimer's disease iPSC-derived neural progenitors.
Andrew A. Sproul,Samson T. Jacob,Deborah Pre,Soong Ho Kim,Michael W. Nestor,Miriam Navarro-Sobrino,Ismael Santa-Maria,Matthew Zimmer,Soline Aubry,John W. Steele,David J. Kahler,Alex Dranovsky,Ottavio Arancio,John F. Crary,Sam Gandy,Scott Noggle +15 more
TL;DR: In this model, induced pluripotent stem cells from affected and unaffected individuals from two families carrying PSEN1 mutations are generated and an essential feature in the molecular pathogenesis of FAD is reconstituted, increased generation of Aβ42/40, and has characterized novel expression changes.
Journal ArticleDOI
Latrepirdine improves cognition and arrests progression of neuropathology in an Alzheimer's mouse model
John W. Steele,M. L. Lachenmayer,M. L. Lachenmayer,Shulin Ju,Aryeh Stock,J. Liken,Soong Ho Kim,Luz Delgado,Iván E. Alfaro,Sebastian Bernales,Giuseppe Verdile,Prashant Bharadwaj,Veer Bala Gupta,Renae Barr,A. Friss,Georgia Dolios,Rong Wang,Dagmar Ringe,Paul E. Fraser,David Westaway,P. St. George-Hyslop,Paul Szabo,Norman R. Relkin,Joseph D. Buxbaum,Charles G. Glabe,Charles G. Glabe,Andrew Asher Protter,Ralph N. Martins,Ralph N. Martins,Ralph N. Martins,Michelle E. Ehrlich,Gregory A. Petsko,Gregory A. Petsko,Zhenyu Yue,Sam Gandy,Sam Gandy +35 more
TL;DR: It is concluded that LAT possesses pro-autophagic properties in addition to the previously reported pro-neurogenic properties, both of which are potentially relevant to the treatment and/or prevention of neurodegenerative diseases.
Journal ArticleDOI
Latrepirdine stimulates autophagy and reduces accumulation of α-synuclein in cells and in mouse brain
John W. Steele,Shulin Ju,M.L. Lachenmayer,M.L. Lachenmayer,J. Liken,Aryeh Stock,Soong Ho Kim,Luz Delgado,Iván E. Alfaro,Sebastian Bernales,Giuseppe Verdile,Prashant Bharadwaj,Veer Bala Gupta,Renae Barr,A. Friss,Georgia Dolios,Rong Wang,Dagmar Ringe,Andrew Asher Protter,Ralph N. Martins,Ralph N. Martins,Ralph N. Martins,Michelle E. Ehrlich,Zhenyu Yue,Gregory A. Petsko,Gregory A. Petsko,Sam Gandy,Sam Gandy +27 more
TL;DR: It is proposed that latrepirdine may represent a novel scaffold for discovery of robust pro-autophagic/anti-neurodegeneration compounds, which might yield clinical benefit for synucleinopathies including Parkinson's disease, Lewy body dementia, rapid eye movement (REM) sleep disorder and/or multiple system atrophy, following optimization of its pro- autophagic and pro-NEurogenic activities.
Journal ArticleDOI
Proneurogenic Group II mGluR antagonist improves learning and reduces anxiety in Alzheimer Aβ oligomer mouse.
Soong Ho Kim,John W. Steele,Star W. Lee,G D Clemenson,T A Carter,K Treuner,R Gadient,P Wedel,Charles G. Glabe,CS Barlow,Michelle E. Ehrlich,Fred H. Gage,Sam Gandy +12 more
TL;DR: Assessment of the therapeutic potential of chronic pharmacological inhibition of Group II mGluR in Dutch APP transgenic mice found it to offer a unique package of relevant properties as an Alzheimer’s disease therapeutic or prophylactic by providing both attenuation of neuropathology and stimulation of repair.
Journal ArticleDOI
Acute blast injury reduces brain abeta in two rodent species.
Rita De Gasperi,Rita De Gasperi,Miguel A. Gama Sosa,Miguel A. Gama Sosa,Soong Ho Kim,John W Steele,Michael C. Shaughness,Eric Maudlin-Jeronimo,Aaron A. Hall,Steven T. DeKosky,Richard M. McCarron,Madhusoodana P. Nambiar,Sam Gandy,Stephen T. Ahlers,Gregory A. Elder +14 more
TL;DR: Levels of the amyloid precursor protein (APP) were increased following blast exposure although there was no evidence of axonal pathology based on APP immunohistochemical staining and strategies aimed at lowering Aβ production may not be effective for treating acute blast injury to the brain.